Fanconi anemia (FA) is a rare genetic disorder characterized by genome instability, increased cancer susceptibility, progressive bone marrow failure (BMF) and various developmental abnormalities resulting from the defective FA pathway. FA is caused by mutations in genes that mediate repair processes of interstrand crosslinks and/or DNA adducts generated by endogenous aldehydes. The UBE2T E2 ubiquitin conjugating enzyme acts in FANCD2/FANCI monoubiquitination, a critical event in the pathway.
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Introduction
Fanconi anemia (FA) is a rare genetic disease characterized by genome instability, cancer predisposition, progressive bone marrow failure (BMF), various developmental abnormalities that often include radial ray anomalies, short stature, and visceral malformations 1 Figure S1 ).
Serendipitously, UBE2T mutations were found in both of them ( Figure 1A -C). The two persons are hereafter designated PNGS-252 (Family 1-II-1 in Figure 1D ) and PNGS-255 (Family 2-II-1 in Figure 1D ) ( Table 1) . They were from unrelated families ( Figure 1D ) living in different geographic locations in Japan. Both individuals displayed typical FA phenotypes, with malformations and hematological abnormalities that necessitated haematopoietic stem cell transplantation (Table 1 ) (see Supplemental Note). Chromosome fragility in lymphocytes (described in Supplemental Table 2 in Hira et al. 14 ) was consistent with the diagnosis of FA.
WES and validation by Sanger sequencing in PNGS-252 revealed an apparent homozygous c.4C>G missense alteration （RefSeq accession: NM_014176.3） , resulting in the amino acid substitution p.Gln2Glu ( Figure 1A ). This mutation must be very rare, because this is not listed in the NHLBI Exome Sequencing Project or the Human Genetic Variation Browser databases. The glutamine residue (Gln2) is highly conserved in the homologs found from vertebrates to worms excluding plants ( Figure   1E , and the mutation is rated as "damaging" by both SIFT and PolyPhen predictions.
The Gln2 is located in the N-terminal helix of UBE2T, which constitutes part of the hydrophobic E3-E2 interaction surface, near the conserved E2 UBC fold 15 ( Figure 1C and 1F). Copy number analysis using WES data suggested that there was a heterozygous deletion across the UBE2T locus in the PNGS-252 sample (data not shown). Indeed, our targeted array comparative genome hybridization (array-CGH)
revealed an area of reduced hybridization signal encompassing almost the entire UBE2T ( Figure 1A ). The deletion junction carried 3 bp of microhomology ( Figure   S2A -D), suggesting that the junction arose from microhomology-mediated repair 16 .
This person's father carried the genomic deletion, while the mother had the heterozygous c.4C>G mutation ( Figure S3 ). There was no family history of malformations, hematological abnormalities, or cancer predisposition.
In We extended WES to AP65P FA fibroblasts provided by the JCRB Cell Bank, and found the same UBE2T c.4C>G mutation. Moreover, 99.9% of the SNPs listed in dbSNP131 and identified in AP65P were identical to those in PNGS-252 (2244 out of 2247), demonstrating that AP65P was derived from PNGS-252 (Table 1 ). The AP65P
individual has been reported as carrying no mutations in FANCA, FANCG, and
We transformed the cells with human TERT (hTERT), and termed them AP65P-hTERT. Unfortunately, we were unable to immortalize bone marrow fibroblasts from PNGS-255.
Interestingly, AP65P-hTERT cells displayed roughly similar protein levels of UBE2T as normal control cells (48BR), indicating that the p.Gln2Glu substitution does not significantly destabilize UBE2T protein ( Figure 2A ). We also detected the auto-monoubiquitinated form of UBE2T as previously described 7, 8 , suggesting that the mutant protein is able to receive activated ubiquitin from the E1 enzyme ( Figure 2A ).
However, only faint amounts of long-form ID proteins were observed even after MMC stimulation ( Figure 2A ). As expected, AP65P-hTERT cells transduced with lentivirus encoding normal UBE2T, but not with the mutant, clearly restored the MMC-induced long form of FANCD2 ( Figure 2A ) as well as FANCD2 foci formation ( Figure 2B ).
Furthermore, both the increased levels of MMC-induced chromosome breakage ( Figure 2C ) and the MMC sensitivity ( Figure 3A ) in AP65P-hTERT cells were suppressed by exogenous wild type UBE2T but not with UBE2T carrying p.Gln2Glu.
Taken together, these results firmly established that the FA phenotype in these individuals is caused by the UBE2T mutations.
How, exactly, does the UBE2T alteration affect the activity of the protein in promoting monoubiquitination of the ID complex? We hypothesized that the p.Gln2Glu substitution might disrupt the FANCL-UBE2T interaction. Indeed, the p.Gln2Glu alteration drastically reduced the signal intensity in a mammalian two-hybrid assay ( Figure 4A ). This was confirmed by a GST pull-down experiment using purified recombinant human or chicken GST-FANCL and wild type or mutant UBE2T proteins ( Figure 4B , 4C, and S6A). In an in vitro monoubiquitination assay 11 , the mutated UBE2T protein displayed ~3-fold less efficiency in promoting FANCD2 monoubiquitination in the presence ( Figure 4D ) or absence ( Figure S6B ) of stimulator DNA, whereas auto-ubiquitination was normal compared to control proteins ( Figure   S6C ). The p.Gln2Glu substitution abrogated FANCL monoubiquitination in vitro ( Figure 4D , S6B and S6D); however, the FANCL-independent FANCI monoubiquitination was not affected ( Figure S6D ) 12 . These results are well explained by the specific disruption of the FANCL-UBE2T interaction by the p.Gln2Glu
substitution.
In conclusion, we propose that UBE2T(FANCT) mutations define a FA subtype. This is also a rare example of a mutated E2 enzyme causing an inherited human disorder, like UBE2A 18 . The p.Gln2Glu substitution is probably hypomorphic, since a siUBE2T knockdown made AP65P-hTERT cells more sensitive to MMC and completely eliminated the trace FANCD2 monoubiquitination that could still be observed in the siLuc control knockdown cells ( Figure 3B and 3C). Finally, it is interesting to note a recent report suggesting that UBE2T functions with an unknown E3 in nucleotide excision repair 19 . It is common for an E2 to function with a set of E3 ligases, since far fewer E2s (~38) are encoded in the genome than E3 ligases (600-1000) 20 . UBE2T may have a partner other than FANCL, such as BRCA1 21 or other E3s, as has been suggested by yeast two hybrid assays 22, 23 , raising the possibility that UBE2T might have a function outside the FA pathway. While a siUBE2T knockdown in AP65P-hTERT modestly sensitized cells to UV ( Figure 3C ), we detected only a marginal impact of UBE2T lentiviral transduction on UV survival ( Figure 3D ). These results suggest that the p.Gln4Glu substitution is a separation of function alteration that specifically reduces UBE2T function in the FA pathway but not in UV resistance. In line with this, neither of our FA-T individuals experienced any photosensitivity. It thus remains unclear whether or how complete loss of UBE2T function would impact human phenotypes.
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The WES sequencing data have been deposited in the European Genome-phenome a The onset of BMF was defined as described 24 . or PNGS-255 (B). In the array-CGH, one of the deletion junctions was outside of our probes installed, and therefore it is impossible to see the whole deletion. A red line indicates the approximate region of the genome deletion detected by genome PCR ( Figure S2 ). A schematic summary is shown in (C). Genomic DNA was isolated from PHA-stimulated lymphocytes using a Puregene (Qiagen) kit. Genomic PCR was carried out using KOD-FX polymerase (TOYOBO) with primer pairs indicated in Table S1 and directly sequenced after ExoSAP-IT (Affymetrix) treatment or after purification from an agarose gel (Nucleospin, Takara). A custom CGH 4x180K array with a total of 179673 50mer probes in triplicate was designed using SureDesign supernatants were filtered and added to the sparsely seeded AP65P-hTERT cells.
Blastocidin S selection was started 2 days later (3 g/ml). For western blotting, collected cells were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 1% NP-40, 5 mM EDTA, 20 mM -glycerophosphate, 50 mM NaF, 1X protease inhibitor (Complete EDTA-free tablet Roche), 50 U/mL Benzonase, 1 mM PMSF). Samples were separated by SDS-polyacrylamide gel electrophoresis, transferred to a membrane, and detected with indicated antibodies and ECL reagents (GE Healthcare) using a LAS4000 Mini apparatus (GE Healthcare). The antibodies used in this study are summarized in Table   S3 .
(B) FANCD2 foci formation. Cells were grown on coverslips and subjected to 100 ng/ml MMC for 24 h. Cells were then permeabilized with 0.5% Triton X-100/PBS for 10 min on ice, and fixed with 3% paraformaldehyde/2% sucrose at room temperature Carnoy's solution (4 ml) was added, followed by centrifugation at 1200 rpm for 10 min.
Cell pellets were washed once with 10 ml Carnoy's solution and resuspended in 1 ml
Carnoy's solution. In each condition, 100 cells were scored. (A) MMC sensitivity assay. AP65P-hTERT cells were exposed to varying concentrations of MMC for 24 h, washed and seeded into 6 well plates. After 5-7 days surviving cells were counted using a LUNA digital automated cell counter (Logos Biosystems) or stained with 0.006% Crystal violet/25% methanol solution. GM6914
(FA-A) and its complemented cells were included as control.
(B) Western blotting using the indicated antibodies (listed in Table S3 ).
AP65P-hTERT cells were transfected with control (siLuc) or siRNAs targeting UBE2T
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